# CooperSurgical

> CooperSurgical is a VC fund in Trumbull backing Medical and Health Care. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Trumbull, United States
- Total investments: 3
- Last investment: Jan 2025
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/coopersurgical
- Website: http://www.coopersurgical.com/

CooperSurgical is a VC fund in Trumbull focused on Medical and Health Care. CooperSurgical offers a full portfolio of medical and surgical products and brands for women's health care that ob/gyns and other clinician.

## Contacts

5 contacts available for CooperSurgical. Shizune tracks 4 team members at CooperSurgical. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/coopersurgical-inc?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Health Care | 1 | 33% |
| Biotechnology | 1 | 33% |
| Machine Learning | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Doug Oberly | Senior Director Regulatory, Special Projects | 0 | — |
| Kerry Blair | Chief Operating Officer | 0 | — |
| Lisa Fawcett | Executive Vice President, Strategy & Market Development | 0 | — |
| Holly Sheffield | Founder & President | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Granata Bio | Granata Bio is a biotechnology focused on identifying and developing therapeutics for fertility patients. Founded in 2018, the Company recently announced a partnership with IBSA Institut Biochimique (Lugano CH) to co-develop a novel subcutaneous progesterone solution. | $15M | Series A | Jan 15, 2025 |  |
| Granata Bio | Granata Bio is a biotechnology focused on identifying and developing therapeutics for fertility patients. Founded in 2018, the Company recently announced a partnership with IBSA Institut Biochimique (Lugano CH) to co-develop a novel subcutaneous progesterone solution. | $14M | Series A | Jan 16, 2024 |  |
| DotLab | Women's health diagnostics using novel biomarkers and machine learning |  | Series A | Jul 01, 2019 |  |

3 of 3 investments shown.

## Co-investors
- [Amboy Street Ventures](https://shizune.co/investors/profile/amboy-street-ventures) — VC Fund, 2 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 1 deal together
- [Google Ventures](https://shizune.co/investors/profile/google-ventures) — VC Fund, 1 deal together
- [Ironwood Ventures](https://shizune.co/investors/profile/ironwood-ventures-2a2e) — VC Fund, 1 deal together
- [Luxor Capital Group](https://shizune.co/investors/profile/luxor-capital-group) — VC Fund, 1 deal together
- [Tiger Global Management](https://shizune.co/investors/profile/tiger-global) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does CooperSurgical invest in?

CooperSurgical invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact CooperSurgical?

Public channels for CooperSurgical include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at CooperSurgical?

The team at CooperSurgical includes Doug Oberly (Senior Director Regulatory, Special Projects), Kerry Blair (Chief Operating Officer) and Lisa Fawcett (Executive Vice President, Strategy & Market Development). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co